Friday, July 31, 2026

Kim Jong-un Places Ju-ae Front And Center In First New Year Visit To Kumsusan Palace[Daily North Korea]

Kim Jong Un visited the Kumsusan Palace with his family for the New Year, marking significant public appearances and national unity.

AWS Launches New Open-Source Tool to Help Developers Build AI Agents

AWS introduces Strands Agents SDK, a tool for building AI agents with minimal coding, enhancing developer efficiency and integration.

ROMEO AND JULIET FROM HELL: The Twisted Internet Obsession With A Trump-Kim Wedding To End The Nuclear Crisis!

A viral meme suggests Barron Trump marry Kim Ju-ae for world peace, sparking mixed reactions on social media amid global tensions.

Tag: SK Biopharmaceuticals

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

SK Biopharmaceuticals Launches U.S. Innovation Hub to Help Korean Biotechs Expand Globally

SK Biopharmaceuticals launched SK Life Science LinX to support Korean biotech firms entering the U.S. market, fostering innovation and collaboration.

SK Biopharmaceuticals Unveils Breakthrough Findings on NTSR1-Targeted Radiopharmaceutical SKL35501

SK Biopharmaceuticals will present findings on NTSR1-targeted treatments at the AACR Annual Meeting, showcasing innovative oncology research.

SK Biopharmaceuticals Selects Two CNS Startups Through Open Innovation… Advances Expected in Parkinson’s and Alzheimer’s Treatment

SK Biopharmaceuticals partners with Seoul Bio Hub to support two CNS startups, Novorex and Threebrooks, in innovative drug development.

Exploring Cenobamate: How SK Biopharmaceuticals’ New Oral Suspension Benefits Adult Epilepsy Patients

SK Biopharmaceuticals submits NDA for Cenobamate oral suspension, enhancing treatment options for epilepsy patients with swallowing difficulties.

SK Biofarm, FDA Approved Radioactive Method: Will it be a Revolutionary Cancer Cure with SLK 33501?

SK Biopharmaceuticals gains FDA approval for Phase 1 trials of radiopharmaceuticals SKL35501 and SKL35502, advancing cancer treatment.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.